We found that nine signaling pathways were significantly predicted to be activated in metastatic ccRCC with low LTF expression but inhibited in nonmetastatic ccRCC with high LTF expression (Figure 4B). This evidence concerns the gene LTF and nonpapillary renal cell carcinoma.